Lukas T J, Wallen-Friedman M, Kung C, Watterson D M
Department of Pharmacology, Vanderbilt University, Nashville, TN.
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7331-5. doi: 10.1073/pnas.86.19.7331.
The Paramecium tetraurelia mutants termed pantophobiacs have altered behavior due to perturbed calcium activation of ion channel activity. The calmodulin from pantophobiac A1 (pntA1) was shown in previous studies to have a single amino acid change at residue 101 that is selective in its effects on activity. This change has no effect on posttranslational modifications. However, the calmodulin from the phenotypically related mutant pantophobiac A2 (pntA2) has a threonine residue at position 136, in the fourth calcium-binding domain, instead of an isoleucine or valine like all other calmodulins. This region of the calmodulin structure is within 4 A of a complementary hydrophobic structure in the third calcium-binding domain, raising the possibility of a perturbation of interdomain interactions in the pntA2 mutant. This possibility is supported by the heterogenous methylation state of lysine-115 in the pntA2 calmodulin. This lysine residue, located in the peptide connecting calcium-binding domains three and four, is fully trimethylated in the wild-type and pntA1 calmodulins. The functional selectivity of these structural changes is demonstrated by the conservation of calmodulin activator activity with a calmodulin-regulated protein kinase that has been used as a standard of comparison. Overall, these results indicate the degree to which the calmodulin can be mutated in vivo without being lethal to the organism, and they provide genetic evidence suggesting that the post-translational methylation state of residue 115 requires the appropriate conformation in addition to the local amino acid sequence.
被称为泛恐惧症患者的四膜虫突变体由于离子通道活性的钙激活受到干扰而出现行为改变。先前的研究表明,泛恐惧症A1(pntA1)的钙调蛋白在第101位残基处有一个单一氨基酸变化,该变化对活性具有选择性影响。这种变化对翻译后修饰没有影响。然而,表型相关的突变体泛恐惧症A2(pntA2)的钙调蛋白在第四个钙结合结构域的第136位有一个苏氨酸残基,而不是像所有其他钙调蛋白那样是异亮氨酸或缬氨酸。钙调蛋白结构的这一区域距离第三个钙结合结构域中的互补疏水结构在4埃以内,这增加了pntA2突变体中结构域间相互作用受到干扰的可能性。pntA2钙调蛋白中赖氨酸-115的异质甲基化状态支持了这种可能性。这个赖氨酸残基位于连接钙结合结构域三与四的肽段中,在野生型和pntA1钙调蛋白中完全三甲基化。这些结构变化的功能选择性通过与用作比较标准的钙调蛋白调节蛋白激酶的钙调蛋白激活剂活性的保守性得到证明。总体而言,这些结果表明钙调蛋白在体内可以发生突变而不致生物体死亡的程度,并且它们提供了遗传证据,表明残基115的翻译后甲基化状态除了需要局部氨基酸序列外还需要适当的构象。